Skip to Main Content
Close
Who We Serve
Overview
Researchers
Authors
Reviewers
Healthcare Professionals
Patients & Their Supporters
Librarians
Health Sciences Industry
Medical Societies
Agents & Distributors
What We Offer
Overview
Journals
Collections
Subject Areas
Books & Book Series
E-Learning Courses
Healthcare Podcasts
Open Access Portfolio
Communications & Outreach
Who We Are
Overview
What We Solve
Accessing Knowledge
Presenting Knowledge
Applying Knowledge
About Us
Publish with Us
Overview
Publish Your Paper
Calls for Papers
Publication Services
Partner Publications
Submit & Publish Open Access
Resources for You
Overview
Exhibitions
Webinars
Case Studies
Fast Facts
News & Media Releases
Experience Karger Blog
The Waiting Room Blog
Search Dropdown Menu
header search
search input
Search input auto suggest
filter your search
All Content
All Journals
Oncology Research and Treatment
Search
Advanced Search
User Tools Dropdown
Register
Login
Toggle Menu
Menu
Content
Articles
Issues
Online First
Early View
About
Details
Contact
Editorial Board
Guidelines
Affiliations
Subscription Rates
Rights & Permissions
Advertising
Submission
Skip Nav Destination
Oncology Research and Treatment
Affiliations
Official Journal of
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e. V.
(DGHO)
Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie
(OeGHO)
Schweizerische Gesellschaft Für Hämatologie
(SGH/SSH)
Arbeitsgemeinschaft Internistische Onkologie in der Deutschen Krebsgesellschaft e. V.
(AIO)
Deutsche Fatigue Gesellschaft e.V.
(DFaG)
Latest
Most Read
Most Cited
Stereotactic Radiotherapy for penile metastasis: case report and systematic literature review
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy of ponatinib versus imatinib in combination with low-intensity chemotherapy, to compare end of therapy with indication for SCT versus TKI, blinatumomab and chemotherapy in optimal responders and to evaluate blinatumomab in suboptimal responders (GMALL-EVOLVE)
What do German Molecular Tumor Boards recommend in patients with PIK3CA mutated tumors? - Launch and first results from the German TEAM-D Transsectoral Molecular Tumor Board exchange platform Deutschland (TEAM-D) -
Evaluation of the Impact of Adaptive Progressive Supervised Resistance Training on Strength and Quality of Life in Patients with Breast Cancer During Chemotherapy: The VALESCO Study
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
